Comment on ‘Red and processed meat consumption and risk of pancreatic cancer: meta-analysis of prospective studies’

por Lightsey, D
Publicado 2012

Diagnostic radiography and adult acute myeloid leukemia: an interview and medical chart review study

por Pogoda, J M, Nichols, P W, Ross, R K, Stram, D O, Thomas, D C, Preston-Martin, S
Publicado 2012

Comment on ‘A comparison of three methods for detecting KRAS mutations in formalin-fixed colorectal cancer specimens’

por Normanno, N, Rachiglio, A, Roma, C, Ciardiello, F, Pinto, C
Publicado 2012

Reply to comment by Normanno et al on ‘A comparison of three methods for detecting KRAS mutations in formalin-fixed colorectal cancer specimens’

por de Castro, D G, Lopez-Rios, F
Publicado 2012

KRAS mutation in colorectal cancer metastases after adjuvant FOLFOX for the primary

por Vauthey, J-N, Kopetz, S, Aloia, T A, Andreou, A
Publicado 2012

Reply: KRAS mutation in colorectal cancer metastases after adjuvant folfox for the primary

por Yoshino, T, Kawamoto, Y, Bando, H, Tsuchihara, K
Publicado 2012

Hypertensive diseases in pregnancy and subsequent lower risk of breast cancer: the common immune and antiangiogenic profile

por Carbillon, L
Publicado 2012

Cancer chemoprevention: a rapidly evolving field

por Steward, W P, Brown, K
Publicado 2013

KRAS and BRAF mutations are rare and related to DNA mismatch repair deficiency in gastric cancer from the East and the West: Results from a large international multicentre study

por van Grieken, N C T, Aoyama, T, Chambers, P A, Bottomley, D, Ward, L C, Inam, I, Buffart, T E, Das, K, Lim, T, Pang, B, Zhang, S L, Tan, I B, Carvalho, B, Heideman, D A M, Miyagi, Y, Kameda, Y, Arai, T, Meijer, G A, Tsuburaya, A, Tan, P, Yoshikawa, T, Grabsch, H I
Publicado 2014

Mechanism and consequences of RAF kinase activation by small-molecule inhibitors

por Holderfield, M, Nagel, T E, Stuart, D D
Publicado 2014

Trabectedin, a drug acting on both cancer cells and the tumour microenvironment

por D'Incalci, M, Badri, N, Galmarini, C M, Allavena, P
Publicado 2014

Evaluation of chemoresponse assays as predictive markers

por Korn, E L, Freidlin, B
Publicado 2015

The impact of socioeconomic status on access to cancer clinical trials

por Sharrocks, K, Spicer, J, Camidge, D R, Papa, S
Publicado 2014

Seasonal variation in the month of birth in patients with skin cancer

por La Rosa, F, Liso, A, Bianconi, F, Duca, E, Stracci, F
Publicado 2014

Clinical utility of RASSF1A methylation in human malignancies

por Grawenda, A M, O'Neill, E
Publicado 2015

Inhibition of histone deacetylases in cancer therapy: lessons from leukaemia

por Ceccacci, Elena, Minucci, Saverio
Publicado 2016

Biological activity of the thyroid TRK-T3 oncogene requires signalling through Shc

por Roccato, E, Miranda, C, Ranzi, V, Gishizki, M, Pierotti, M A, Greco, A
Publicado 2016

Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer

por Dalgleish, Angus G, Stebbing, Justin, Adamson, Douglas J A, Arif, Seema Safia, Bidoli, Paolo, Chang, David, Cheeseman, Sue, Diaz-Beveridge, Robert, Fernandez-Martos, Carlos, Glynne-Jones, Rob, Granetto, Cristina, Massuti, Bartomeu, McAdam, Karen, McDermott, Raymond, Martín, Andrés J Muñoz, Papamichael, Demetris, Pazo-Cid, Roberto, Vieitez, Jose M, Zaniboni, Alberto, Carroll, Kevin J, Wagle, Shama, Gaya, Andrew, Mudan, Satvinder S
Publicado 2016

Comment on ‘Molecular evidence of viral DNA in non-small cell lung cancer and non-neoplastic lung’

por Ponzetto, Antonio, Figura, Natale, Holton, John
Publicado 2017

Comment on ‘Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome’

por Dell'Oglio, Paolo, Stabile, Armando, Gandaglia, Giorgio, Briganti, Alberto
Publicado 2017